This week, Cantech Letter spoke to CEO Ashish Malik of Bee Vectoring, who gave a presentation on the company on Tuesday at the 2019 Cantech Investment Conference in Toronto.
“2019 is frankly a huge year for us,” Malik said. “It’s the year in which we transition from being an R&D company into a commercialization company. It’s about getting our EPA registration later in the year, which gives us the freedom to operate throughout the United States.”
“In terms of a national campaign, that will come after the EPA registration, which is a critical milestone for us in 2019,” he said. “What that really does is validate us in the eyes of potential partners internationally. That will allow us to speed up market expansion globally.”
BVT’s novel technology uses bumblebees and honeybees to deliver fungicidal power to crops, providing a much more targeted delivery than other approaches. Currently, Bee Vectoring’s system is being used on just one per cent of Florida’s strawberry fields.
Stifel analyst Justin Keywood said in an April 23 update that management commentary from WELL Health Technologies (WELL Health Technologies… [Read More]
iA Global Asset Management portfolio manager Dan Rohinton told BNN Bloomberg’s Market Call on April 21 that Taiwan Semiconductor (Taiwan… [Read More]
Kingwest & Company managing director Tim Regan told BNN Bloomberg’s Market Call on April 20 that EQB (EQB Stock Quote,… [Read More]
National Bank of Canada Capital Markets analyst Cameron Doerksen said in a note ahead of Cargojet’s (Cargojet Stock Quote, Chart,… [Read More]
Roth Capital analyst Scott Searle reiterated a “Buy” rating and $85.00 12-month price target on Calix (Calix Stock Quote, Chart,… [Read More]
In an April 20 sector update, Paradigm Capital analyst Daniel Rosenberg said small-cap technology is showing signs of a risk… [Read More]